Thematic group meetings (only for ERN-Skin members)

Find below the details of our upcoming Thematic group meetings. These meetings are only open for ERN-Skin members. If you have any questions, you can contact:

Date and time

Thematic group

 27th February 2025 from 12:30 pm – 1:30 pm CET

Inherited Epidermolysis Bullosa and skin fragility syndromes – Darier disease – Hailey-Hailey disease (EB)

*Please note that there is also an EB CPMS meeting from 1:30 pm to 2:30 pm CET (right after this one).

 27th February 2025 from 2:30 pm – 3:30 pm CET

Ectodermal Dysplasias including Incontinentia Pigmenti and p63-associated disorders (ED)

*Please note that there is also an ED CPMS meeting from 3:30 pm to 4:30 pm CET (right after this one).

 4th March 2025 from 6:00 pm – 7:00 pm CET

Genodermatoses 2 big group

11th April 2025 from 2:30 pm – 3:30 pm CET

Cutaneous Mosaic Disorders Naevi & Naevoid skin disorders, complex vascular malformations and vascular tumors (MOSAIC)

22nd April 2025 from 9:30 am – 10:30 am CET

Mendelian Connective Tissue Disorders (MCTD)

*Please note that there is also a MCTD CPMS meeting from 10:30 am to 11:30 am CET (right after this one).

12th May 2025 from 4:30 pm – 5:30 pm CET 

Ichthyosis and Palmoplantar Keratoderma (IPPK)

*Please note that there is also an IPPK CPMS meeting from 5:30 pm to 6:30 pm CET (right after this one).

13th May 2025 from 1:30 pm – 2:30 pm CET 

Ectodermal Dysplasias including Incontinentia Pigmenti and p63-associated disorders (ED)

*Please note that there is also an ED CPMS meeting from 2:30 pm to 3:30 pm CET (right after this one).

20th Mai 2025 from 12:30 pm – 1:30 pm CET

Inherited Epidermolysis Bullosa and skin fragility syndromes – Darier disease – Hailey-Hailey disease (EB)

*Please note that there is also an EB CPMS meeting from 1:30 pm to 2:30 pm CET (right after this one).

22nd May 2025 from 2:30 pm – 3:30 pm CET

Cutaneous Diseases related to DNA repair Disorders and photosensitivity (DNA+)

 11th June 2025 at 6:00 pm CET

AIBD-Toxiten big Group Meeting

9th September 2025 from 9:30 am – 10:30 am CET

Mendelian Connective Tissue Disorders (MCTD)

*Please note that there is also a MCTD CPMS meeting from 10:30 pm to 11:30 pm CET (right after this one).

 9th September 2025 from 1:30 pm – 2:30 pm CET

Ectodermal Dysplasias including Incontinentia Pigmenti and p63-associated disorders (ED)

*Please note that there is also an ED CPMS meeting from 2:30 pm to 3:30 pm CET (right after this one).

12th September 2025 from 2:30 pm – 3:30 pm CET

Cutaneous Mosaic Disorders Naevi & Naevoid skin disorders, complex vascular malformations and vascular tumors (MOSAIC)

23rd September 2025 from 12:30 pm – 1:30 pm CET

Cutaneous Diseases related to DNA repair Disorders and photosensitivity (DNA+)

6th October 2025 from 2:30 pm – 3:30 pm CET

Ichthyosis and Palmoplantar Keratoderma (IPPK)

*Please note that there is also an IPPK CPMS meeting from 3:30 pm to 4:30 pm CET (right after this one).

 6th November 2025 at 6:00 pm CET

AIBD-Toxiten big Group Meeting

Previous thematic group meetings

14th January 2025 from 12:30 pm – 1:30 pm CET 

Thematic Group meeting on Cutaneous Diseases related to DNA repair Disorders and photosensitivity (DNA+)

*Please note that there is also a DNA+ CPMS meeting from 1:30 pm to 2:30 pm CET (right after this one).


27th January 2025 from 3:30 pm – 4:30 pm CET

Thematic Group meeting on Ichthyosis and Palmoplantar Keratoderma (IPPK)


5th February 2025 from 1:30 pm – 2:30 pm CET

Mendelian Connective Tissue Disorders (MCTD)

*Please note that there is also a MCTD CPMS meeting from 2:30 pm to 3:30 pm CET (right after this one).


12th February 2025 from 8:30 am – 10:30 am CET

Acquired immunologicaL LOw prevalence and Complex AdulT diseases of thE SKIN (ALLOCATE)


12th February 2025 from 6:00 pm – 7:00 pm CET

AutoImmune Bullous Diseases (AIBD) and Severe Cutaneous Drug Reactions – Toxic Bullous Diseases (ToxiTEN)


14th February 2025 from 2:30 pm – 3:30 pm CET

Cutaneous Mosaic Disorders Naevi & Naevoid skin disorders, complex vascular malformations and vascular tumors (MOSAIC)